Form D · Biotechnology

Juvenescence Ltd

Douglas, Y8 · CIK 0001724307

Offering snapshot reported Jun 7, 2021 · SEC filing

Reported sold
$9.45M
Indefinite offering
Investors reported
15
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Dec 17, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.73M$9.45MApr 8, 2021: $6,450,000.00Apr 8, 2021Jun 7, 2021: $9,450,000.00Jun 7, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,450,000 → $9,450,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 7, 2021Amendment$9,450,000$3,000,000vs Apr 8, 202115SEC filing
Apr 8, 2021Amendment$6,450,000No comparisonNot reportedSEC filing
Jan 4, 2021Initial$2,050,000No comparison5SEC filing
Apr 17, 2020Initial$56,902,324No comparison52SEC filing
Jul 6, 2018Initial$53,082,465No comparison71SEC filing
Dec 6, 2017Initial$2,511,760No comparison0SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-385098
Convertible promissory notes

Source: Form D, filed Jun 7, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gregory Bailey Director, Executive
Susan Bergin Executive
Declan Doogan Director, Executive
Denham Eke Director
David Ellam Executive
Karim Hakimzadeh Director
James Mellon Director, Executive
Alex Pickett Executive
Jean Christophe Renondin Director
David Roblin Executive
Colin Watts Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
18 Athol Street
Douglas, Y8, IM1 1JA